COkay

Pfizer, Inc.(PFE)

C

Financial data as of Dec 31, 2025Declining · Healthcare

FCF Margin14.5%Free Cash Flow / Revenue
Cash Conversion150.6%Operating CF / Net Income
Free Cash Flow$9.1B
Revenue$62.6B
Net Cash-$62.8BNet debt position
Debt / FCF7.0xElevated debt burden
Current Ratio1.16Adequate short-term liquidity
YoY FCF Growth-22.4%4 of 5 quarters positive

How This Grade Was Calculated

Base grade from FCF margin, adjusted by financial health factors

BaseB
-1High debt-to-FCF ratio (7.0x)
+0.5Healthy FCF margin with manageable debt (14.5%, 7.0x)
-0.5FCF trend declining (-22.4% YoY)
-0.5Highly volatile FCF (consistency: 0.83)
FinalC

Analysis Summary

Strengths

  • Healthy FCF margin (14.5%)
  • Excellent cash conversion (151%)

Concerns

  • Heavy debt position ($62.8B net debt, 7.0x FCF)
  • High debt-to-FCF ratio (7.0x)
  • Significant YoY FCF decline (-22.4%)
  • Highly volatile quarterly FCF

Financial Breakdown

Key financials compared side by side

Margin Composition

FCF Margin14.5%
Net Margin12.4%
Operating CF Margin18.7%
CapEx Ratio4.2%

Balance Sheet Health

Debt, liquidity, and leverage snapshot

Net Cash-$62.8BNet debt position
Debt / FCF7.0xElevated debt burden
Current Ratio1.16Adequate liquidity
Debt / Equity0.74Low leverage

Quarterly FCF Trend

-22.4% YoYDeclining (-22.4%)

Free cash flow per quarter

Sector Comparison — Healthcare

FCF Margin ranked against sector peers

View all →

Detailed Metrics

Company NamePfizer, Inc.
SectorHealthcare
Free Cash Flow$9.1B
Revenue$62.6B
Net Income$7.8B
Operating Cash Flow$11.7B
Capital Expenditure$2.6B
FCF Margin14.5%
Cash Conversion Rate150.6%
Net Margin12.4%
Total Debt$64.0B
Total Cash$1.1B
Net Cash-$62.8B
Current Ratio1.16
Debt / Equity0.74
Debt / FCF7.0x
YoY FCF Growth-22.4%
Positive Quarters4 of 5
Trend DirectionDeclining
Report DateDec 31, 2025
GradeC
Data SourceYahoo Finance